All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Mon 2012-12-10? to Fri 2025-11-28 |
YTD
Return |
TR
Price |
||||
|---|---|---|---|---|---|---|
| ABBV × |
+32.62%
2025-11-28 |
10.93 TR
2025-11-28 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10? to Fri 2025-11-28 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ABBV × |
+993.38%
+20.26%/yr |
+17.67%/yr
(R2=0.958) |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10? to Fri 2025-11-28 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| ABBV × |
$10,000.00
2012-12-10 |
$109,338.16
2025-11-28 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Year | ABBV |
|---|---|
| 2025 (YTD) | +32.62% |
| 2024 | +18.87% |
| 2023 | −0.23% |
| 2022 | +24.01% |
| 2021 | +32.43% |
| 2020 | +27.72% |
| 2019 | +1.47% |
| 2018 | −0.96% |
| 2017 | +60.08% |
| 2016 | +9.79% |
| 2015 | −6.50% |
| 2014 | +27.92% |
| 2013 | +60.77% |
| 2012 | −2.40% |
| Mon 2012-12-10? to Fri 2025-11-28 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| ABBV × | −6.15% |
−45.09%
2019-08-15 |
||||
| AbbVie Inc NYSE Common Stock | ||||||